ArticleEJNMMI radiopharmacy and chemistry2024

Modified poly-L-lysine for use as a clearing agent in pretargeted radioimmunotherapy.

Chiara Timperanza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.